European stocks and U.S. equity futures trade higher as investors welcome U.S. stimulus package and Brexit deal

0
45
European stocks and U.S. equity futures trade higher as investors welcome U.S. stimulus package and Brexit deal


European stocks rose Monday, alongside U.S. equity futures as investors welcomed news that President Donald Trump signed a $900 billion pandemic aid bill, and cheered last week’s post-Brexit trade agreement.

The Stoxx Europe 600 index
SXXP,
+0.61%

rose 0.6% to 398.24, while the German DAX
DAX,
+1.47%

jumped 1.5%. The French CAC 40
PX1,
+0.94%
,
the FTSE MIB Italy
I945,
+0.92%

index and Spain’s IBEX 35
IBEX,
+0.59%

gained around 0.8% each.

The FTSE 100 index
UKX,
+0.10%

was closed for an extended holiday break, but the British pound
GBPUSD,
-0.04%

surged 1.6% to $1.3568 on relief over a historic deal agreed on Christmas Eve to define the U.K. and EU trade relationship after Brexit.

The deal, which comes into force on Jan. 1, covers trade that was worth £668 billion ($905 billion) in 2019 and guarantees tariff-free trade on most goods, said U.K. Prime Minister Boris Johnson, who lauded the the deal, along with Ursula von der Leyen, president of the European Commission.

“The signing of the Brexit trade agreement was a massive sigh of relief to financial markets, which had spent the last few months buying sterling in anticipation of the outcome,” said Jeffrey Halley, senior market analyst, Asia Pacific, at OANDA, in a note to clients.

He said sterling was likely headed to $1.3800 in coming weeks, but markets would likely “wait until next week though before buying again, fearful of massive bottlenecks at the English Channel as the new rules take effect.”

U.S. stock futures traded higher, with Dow futures
YM00,
+0.44%

up over 100 points. After holding out for days amid demands for bigger relief checks, Trump finally signed the massive bill at his private club in Florida on Sunday. In a statement, he said Congress would vote on lifting individual payments from the current $600 to $2,000.

House Democrats last week tried to do just that, but were blocked by Republicans, who have split with Trump on the package. House Speaker Nancy Pelosi said she would hold another vote on Monday.

Read: ‘More help is on the way’: The long wait is over for second stimulus check, but will $600 be enough?

The “possibility of an increase in direct payments above $600 should be a market positive on top of the boost received from the president’s signature. With one eye on the Georgia Senate runoff on January 5, politicians from both sides may also feel slightly more generous than a week ago,” said Halley.

Drugmakers in general were leading the gains among Europe stocks on Monday, with shares of Novartis
NVS,
+0.19%

NOVN,
+2.34%

up 1.8% and Roche Holding
ROG,
+1.36%

up 0.7%. In Germany, shares of Bayer
BAYN,
+2.15%

rose 2%.

Europe kicked off its COVID-19 vaccination program over the weekend, using the vaccine developed by Germany’s BioNTech 
BNTX,
-3.10%

and American drugmaker Pfizer
PFE,
-0.45%

0Q1N,
.

AstraZeneca
AZN,
-0.51%

AZN,
-0.01%

Chief Executive Pascal Soriot said Sunday that researchers believe the COVID-19 vaccine it is developing with Oxford University will work against a new strain of the virus driving a surge in U.K. infections. That vaccine is widely expected to gain U.K. approval this week. Shares of AstraZeneca were modestly higher.



Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here